Lotus Chooses AWS as Its Preferred Cloud Provider to Advance Connected and Automated Vehicles
At AWS re:Invent, Amazon Web Services (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced that Lotus Technology (“Lotus”, NASDAQ:LOT), a leading global intelligent and luxury mobility provider, has chosen AWS as its preferred cloud provider to help support its development of intelligent, luxury car experiences. The automaker will use AWS to implement its Vision80 Strategy, a plan to transform the company into a global luxury technology brand by 2028.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241202319353/en/
(Photo: Business Wire)
With more than 70 years of racing heritage and automotive leadership, Lotus offers market-leading standards in performance, design and engineering. Lotus is dedicated to delivering luxury electric vehicles, with a focus on developing next-generation electric and digital technologies. Lotus will apply AWS technologies, including Internet of Things (IoT), analytics, machine learning, and generative artificial intelligence (AI), to develop and deliver connected features, such as autonomous driving solutions, immersive infotainment, and hyper-fast vehicle charging.
Advancing autonomous and connected capabilities for vehicles
Lotus runs its ROBO Soul self-driving software stack on AWS, enabling cars and trucks, including Lotus next-generation electric vehicles, to automatically perform tasks such as parking and highway driving. Using AWS, Lotus also developed ROBO Galaxy, a platform of intelligent driving tools, to help fleet managers increase the efficiency and accessibility of autonomous vehicles in international markets. Lotus leverages Amazon Redshift and Amazon Managed Streaming for Apache Kafka (Amazon MSK) to create their intelligent driving tools and uses Amazon Glue for data integration. AWS enables Lotus to analyze crucial information—such as real-time maps, traffic conditions, and driver behavior—to help enhance their intelligent driving system’s capabilities and help support a safer driving experience. For example, Lotus’ driving system uses technologies, including AWS, to automatically brake if an object is too close to the front of the vehicle.
Lotus Connect, Lotus’s connected-vehicle platform, runs on AWS and provides Lotus customers with remote vehicle control, real-time status monitoring, geofencing, and stolen-vehicle tracking to enable smarter, safer, and more convenient driving experiences. For example, the system provides ongoing monitoring that proactively sends driver notifications, automatically detects maintenance issues, and summons roadside assistance for on-demand help. Lotus Connect uses Amazon Elastic Kubernetes Service (Amazon EKS) to quickly deploy, manage, and scale containerized application. The connected vehicle platform’s autonomous driving module processes sensory input to understand the driving environment and help drivers make decisions, reducing deployment time from six months to two weeks. Additionally, using Amazon Aurora, a high-performance relational database service with more than 99.99% availability, Lotus achieves application latency of less than 2.2 seconds for its Lotus Digital Key, a next-generation car key that can be accessed from drivers’ Apple Wallets. Drivers can share their digital key with family and friends, as well as lock, unlock, and start their vehicle from their iPhone or Apple Watch without an internet connection or physical key.
Personalizing driver experiences and vehicles
Lotus uses AWS analytics to gain business insights, analyze car buying, and make tailored purchasing recommendations. Using Amazon CloudFront, AWS’s content delivery network, Lotus offers real-time 3D vehicle rendering for personalized customization and an immersive car-buying experience. This enables Lotus to suggest and preview new model configurations in 3D, giving customers an idea of how their cars would look with distinctive accessories, colors, and trim packages, including a curated selection of limited-edition designs sourced from collaborations with partners, artists, and luxury brands.
“AWS’s technologies help us accelerate our global growth by allowing Lotus to build solutions for intelligent driving, connected cars, and personalized experiences,” said Bo Li, vice president of Lotus Technology. “We are excited to work with AWS to apply new technologies like generative AI, which will help us improve Lotus’ automated driving capabilities, develop more responsive customer service, and improve driver satisfaction. We look forward to deepening our partnership to create an enhanced and more responsive in-vehicle experience.”
“The automotive industry is experiencing a seismic shift to digitization and electrification, and the cloud is helping drive this rapid development,” said Ozgur Tohumcu, general manager, Automotive & Manufacturing, AWS. “Working collaboratively, AWS will help Lotus as they continuously innovate on more personalized, connected, and intelligent in-vehicle experiences. We look forward to continuing our collaboration, applying generative AI to help drive efficiencies and bring new connected car capabilities, enhanced vehicle features leveraging self-driving capabilities, and elevated driving experiences.”
About Amazon Web Services
Since 2006, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud. AWS has been continually expanding its services to support virtually any workload, and it now has more than 240 fully featured services for compute, storage, databases, networking, analytics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, media, and application development, deployment, and management from 108 Availability Zones within 34 geographic regions, with announced plans for 18 more Availability Zones and six more AWS Regions in Mexico, New Zealand, the Kingdom of Saudi Arabia, Taiwan, Thailand, and the AWS European Sovereign Cloud. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com.
About Amazon
Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Amazon strives to be Earth’s Most Customer-Centric Company, Earth’s Best Employer, and Earth’s Safest Place to Work. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Career Choice, Fire tablets, Fire TV, Amazon Echo, Alexa, Just Walk Out technology, Amazon Studios, and The Climate Pledge are some of the things pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241202319353/en/
Contacts
Amazon.com, Inc.
Media Hotline
Amazon-pr@amazon.com
www.amazon.com/pr -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.amazon.com%
2Fpr&esheet=54159714&newsitemid=20241202319353&lan=en-US&anchor=www.amazon.com%2
Fpr&index=8&md5=21dc3821f2e110d731a6651e8a352d28
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA’s Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 202531.5.2025 15:00:00 EEST | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today will present new data from the Arm C and D cohorts of the pivotal, global Phase 3 SEQUOIA trial of BRUKINSA® (zanubrutinib). The findings underscore the strong and consistent efficacy of BRUKINSA across CLL patient types, including high-risk mutation status. These data will be presented in two rapid oral presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. Data from the Arm D of SEQUOIA demonstrate that treatment with BRUKINSA plus venetoclax has the potential to drive progression-free survival and overall deep and durable responses across the frontline CLL patient spectrum, including patients with high-risk mutational status. The best undetectable minimal residual disease (uMRD) rate in peripheral blood at a sensitivity level 10-4 was 59%. These efficacy responses observed in Arm D, despite the high proportion of high-risk patients enrolled, are in
You Up? Grindr’s “Right Now” Goes Global30.5.2025 16:00:00 EEST | Press release
Grindr, the Global Gayborhood in Your Pocket™ with more than 14.6M average monthly active users, today announced the global launch of Right Now, their newest intent-based feature designed to instantly connect people looking for immediate encounters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250530651954/en/ Grindr's Right Now feature. Right Now is a real-time feed—separate from the app’s main grid that displays profiles—where Grindr users can post text and share photos displayed for one hour, letting other like-minded users know exactly what they’re looking for. “Right Now empowers our users to find exactly what they want, when they want it – without the guesswork,” said AJ Balance, Chief Product Officer at Grindr. “We built this intention-based feature based on feedback from our community so they can connect with like-minded people without wasting time on mismatched expectations. The response to our initial March launc
CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 203030.5.2025 15:00:00 EEST | Press release
Today an international coalition announces the launch of CAR T Vision to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy. By 2030, the aim is to double the proportion of eligible patients treated with CAR T-cell therapy. As outlined in the new roadmap report, the coalition will work to address access challenges and drive meaningful change in the CAR T-cell therapy healthcare ecosystem with a focus on three critical priorities: increasing awareness and understanding of CAR T-cell therapy; expanding resources and capacity to deliver CAR T-cell therapy; and developing sustainable and innovative financing approaches to manage the costs of treatment and care. “Despite CAR T-cell therapy being available in the United States for nearly seven years in large B-cell lymphoma, only approximately two out of 10 eligible patients with some advanced blood cancers ever receive CAR T-cell therapy,” said Miguel Perale
Indian Educationist Dr. Achyuta Samanta Recognised With Research Institute in His Name at CUNY, USA30.5.2025 12:17:00 EEST | Press release
In a noteworthy development underscoring growing academic collaboration between India and the United States, the City University of New York (CUNY) has launched a dedicated research platform—the Achyuta Samanta India Initiative of the CUNY CREST Institute (ASIICCI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529012005/en/ Dr. Milton Santiago, President of Bronx Community College, and Dr. Achyuta Samanta, Founder of KIIT & KISS, jointly inaugurate the Achyuta Samanta India Initiative of CUNY CREST Institute (ASIICCI) with a ribbon-cutting ceremony in New York. Named after Dr. Achyuta Samanta, a noted Indian educationist and social worker, the initiative focuses on academic research in Indian social and educational sectors, with a particular lens on Odisha. This marks one of the rare instances of a living Indian being honoured with such a naming in an American public university system. Dr. Samanta, who hails from Odisha
FDA Grants De Novo Clearance for Reflow Medical's Spur ® Peripheral Retrievable Stent System30.5.2025 07:08:00 EEST | Press release
Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the company’s Spur Peripheral Retrievable Stent System, a unique clinical solution for the treatment of de novo or restenotic lesions following predilatation in patients with infrapopliteal arterial disease. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529610368/en/ The first and only retrievable stent system that features a self-expanding stent with an integrated dilatation balloon catheter on an over-the-wire system. It is designed for controlled lesion penetration and treatment through a series of radially expandable spikes. Known as Retrievable Scaffold Therapy (RST), the spikes on the Spur Stent penetrate the lesion to increase the acute luminal diameter and modify the lesion morphology to change vessel complia
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom